Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2020 加拿大临床实践指南：成人肥胖

2020-08-04 国外内分泌相关专家小组（统称） CMAJ . 2020 Aug 4;192(31):E875-E891.

肥胖

肥胖是一种复杂的慢性疾病可损害身体健康，增加长期并发症风险缩短寿命。本文是对2006年加拿大肥胖指南的更新，主要目的是为基层医疗工作者在i评估和治疗肥胖患者时提供指导。

中文标题：

2020 加拿大临床实践指南：成人肥胖

英文标题：

Obesity in adults: a clinical practice guideline

发布机构：

国外内分泌相关专家小组（统称）

发布日期：

2020-08-04

简要介绍：

肥胖是一种复杂的慢性疾病可损害身体健康，增加长期并发症风险缩短寿命。本文是对2006年加拿大肥胖指南的更新，主要目的是为基层医疗工作者在i评估和治疗肥胖患者时提供指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 加拿大临床实践指南：成人肥胖.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f37431c001951246, title=2020 加拿大临床实践指南：成人肥胖, enTitle=Obesity in adults: a clinical practice guideline, guiderFrom=CMAJ . 2020 Aug 4;192(31):E875-E891., authorId=0, author=, summary=肥胖是一种复杂的慢性疾病可损害身体健康，增加长期并发症风险缩短寿命。本文是对2006年加拿大肥胖指南的更新，主要目的是为基层医疗工作者在i评估和治疗肥胖患者时提供指导。, cover=https://img.medsci.cn/2020812/1597199537802_2020535.jpg, journalId=0, articlesId=null, associationId=949, associationName=国外内分泌相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Tue Aug 04 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>肥胖是一种复杂的慢性疾病可损害身体健康，增加长期并发症风险缩短寿命。本文是对2006年加拿大肥胖指南的更新，主要目的是为基层医疗工作者在i评估和治疗肥胖患者时提供指导。</p> </div> </div> </div>, tagList=[TagDto(tagId=332, tagName=肥胖)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=332, guiderKeyword=肥胖, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3925, appHits=207, showAppHits=0, pcHits=801, showPcHits=3718, likes=3, shares=24, comments=9, approvalStatus=1, publishedTime=Wed Aug 12 10:40:17 CST 2020, publishedTimeString=2020-08-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Aug 12 10:32:22 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:11:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 加拿大临床实践指南：成人肥胖.pdf)])
2020 加拿大临床实践指南：成人肥胖.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954501, encodeId=6a81954501f1, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:50 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954656, encodeId=7c4195465649, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:26:52 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949114, encodeId=e9ea949114fd, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=227b5470319, createdName=ms2000000038807668, createdTime=Wed Mar 17 23:24:44 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881572, encodeId=daa58815e2fc, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60db2429725, createdName=123b32e1m46暂无昵称, createdTime=Tue Sep 01 00:58:52 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812074, encodeId=178d8120e405, content=好，受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Aug 22 18:11:48 CST 2020, time=2020-08-22, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅！好文章。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954501, encodeId=6a81954501f1, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:50 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954656, encodeId=7c4195465649, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:26:52 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949114, encodeId=e9ea949114fd, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=227b5470319, createdName=ms2000000038807668, createdTime=Wed Mar 17 23:24:44 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881572, encodeId=daa58815e2fc, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60db2429725, createdName=123b32e1m46暂无昵称, createdTime=Tue Sep 01 00:58:52 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812074, encodeId=178d8120e405, content=好，受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Aug 22 18:11:48 CST 2020, time=2020-08-22, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好，但无法分享，遗憾！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954501, encodeId=6a81954501f1, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:50 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954656, encodeId=7c4195465649, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:26:52 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949114, encodeId=e9ea949114fd, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=227b5470319, createdName=ms2000000038807668, createdTime=Wed Mar 17 23:24:44 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881572, encodeId=daa58815e2fc, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60db2429725, createdName=123b32e1m46暂无昵称, createdTime=Tue Sep 01 00:58:52 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812074, encodeId=178d8120e405, content=好，受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Aug 22 18:11:48 CST 2020, time=2020-08-22, status=1, ipAttribution=)]
    2021-03-17 ms2000000038807668

    积分不够

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=954501, encodeId=6a81954501f1, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:50 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954656, encodeId=7c4195465649, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:26:52 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949114, encodeId=e9ea949114fd, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=227b5470319, createdName=ms2000000038807668, createdTime=Wed Mar 17 23:24:44 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881572, encodeId=daa58815e2fc, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60db2429725, createdName=123b32e1m46暂无昵称, createdTime=Tue Sep 01 00:58:52 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812074, encodeId=178d8120e405, content=好，受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Aug 22 18:11:48 CST 2020, time=2020-08-22, status=1, ipAttribution=)]
    2020-09-01 123b32e1m46暂无昵称

    真好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=954501, encodeId=6a81954501f1, content=受益匪浅！好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:10:50 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954656, encodeId=7c4195465649, content=资料好好，但无法分享，遗憾！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:26:52 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949114, encodeId=e9ea949114fd, content=积分不够, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=227b5470319, createdName=ms2000000038807668, createdTime=Wed Mar 17 23:24:44 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881572, encodeId=daa58815e2fc, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60db2429725, createdName=123b32e1m46暂无昵称, createdTime=Tue Sep 01 00:58:52 CST 2020, time=2020-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812074, encodeId=178d8120e405, content=好，受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3e642424157, createdName=123a16c8m00暂无昵称, createdTime=Sat Aug 22 18:11:48 CST 2020, time=2020-08-22, status=1, ipAttribution=)]
    2020-08-22 123a16c8m00暂无昵称

    好，受益匪浅

    0

相关指南

2020 FISPGHAN意见书：儿童时期肥胖的预防

国际儿童胃肠病学、肝病学和营养学会联盟(FISPGHAN,Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition) · 2020-03-20

2020 ESE临床实践指南：肥胖的内分泌检查

欧洲内分泌学会(ESE,European Society of Endocrinology) · 2020-01-10

2016 ISTH指南：使用直接口服抗凝剂治疗肥胖患者

国际血栓与止血学会(ISTH,International Society on Thrombosis and Haemostasis) · 2016-04-27

2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质

美国心衰学会(HFSA,HEART FAILURE SOCIETY OF AMERICA) · 2019-03-12

2016年中国超重/肥胖医学营养治疗专家共识解读

暂未更新 · 2017-05-30

儿童肥胖筛查和治疗的承诺和机会：USPSTF建议声明 2017

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2017-06-24

拓展阅读

2011 IDF 减重手术治疗肥胖伴2型糖尿病的立场声明

国际糖尿病联盟(IDF,International Diabetes Federation) · 2011-03-03

2011CES 中国成人肥胖症防治专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2011-09-01

2012AHA关于父母行为改变策略与代沟研究证据的科学声明：父母和成人监护人作为&ldquo;变更代理人&rdquo;治疗儿童肥胖症的效果评估

美国心脏协会(AHA,American Heart Association) · 2012-01-23

ASCO指南：肥胖癌症患者合适的化疗剂量

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2012-04-02

2012EASO/ESH 肥胖和难治性动脉高血压联合声明

欧洲肥胖症研究学会(EASO,European Association for the Study of Obesity) · 2012-06-05

2012 EASO指南：老年人肥胖的患病率、病理生理、健康后果和治疗选择

欧洲肥胖症研究学会(EASO,European Association for the Study of Obesity) · 2012-06-20

Baidu
map
Baidu
map
Baidu
map